“The
Report Obsessive-Compulsive Disorder-API Insights, 2014 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz”
The active pharmaceutical
ingredients worldwide market is in continuous development from the
recent years. There is expected to be a major impact on the global
API industry, with the large number of blockbuster drugs going off
patent in the coming years. It is going to affect the revenue of the
API market as generic drugs occupy the market.
View
Full Report at http://www.marketresearchreports.biz/analysis/232428
India and China produce a
large percentage of a majority of the APIs and intermediates produced
in the world currently. The USFDA and EMA have strict guidelines for
API manufacturing 'Process Validation: General Principles and
Practices'. While countries such as Japan and Singapore are
signatories to the ICH Q7 regulation, India and China follow their
national GMP guidelines. The efficiency and expertise of Asian
contract manufacturers have positioned them in a very strategic space
in the global pharmaceutical supply chain, with a vast majority of
the APIs and intermediates being sourced from markets such as India
and China.
DelveInsight’s,
Obsessive-Compulsive Disorder -API Insights, 2014 Report describes
the current therapeutics that are propelling the pharmaceutical
markets worldwide. The report gives the clear idea on the United
States Drug Master File (USDMF) and Europe DMF filed by worldwide
countries related to the Obsessive-Compulsive Disorder. It also
provides the India and China API Manufactures who are driving the
current API Market. The report also highlights the patent and patent
exclusivity information. The research analysis also presents the
global sales forecasts data till 2015.
DATA
SOURCES
The report is built using data
and information sourced from proprietary databases, primary and
secondary research and in-house analysis by DelveInsight team of
industry experts. Secondary sources information and data has been
collected from various printable and non-printable sources like
search engines, News websites, Government Websites, Trade Journals,
White papers, Magazines, Trade associations, Books, Industry Portals,
Industry Associations and access to available databases.
Note: Certain sections in the
report may be removed or altered based on the availability and
relevance of data for the indicated disease.
SCOPE
- A snapshot of the global Market therapeutics scenario for Obsessive-Compulsive Disorder.
- A review of the marketed products under prescription for Obsessive-Compulsive Disorder, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Obsessive-Compulsive Disorder with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Obsessive-Compulsive Disorder drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Obsessive-Compulsive Disorder drugs.
- Key discontinued Marketed products.
- Global Sales Figure from 2011-2015.
Download
Detail Report With Complete TOC at
http://www.marketresearchreports.biz/sample/sample/232428
REASONS
TO BUY
- Evaluate the marketing status and exclusivity details of Obsessive-Compulsive Disorder key products to exploit opportunities for generic drug development opportunities.
- Key players in the pharmaceutical industry.
- Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Obsessive-Compulsive Disorder.
- API intelligence over marketed drugs for Obsessive-Compulsive Disorder and gaining primary intelligence over active ingredients manufacturers across the globe.
- Uncovering opportunities in the rapidly growing the US markets.
Table
of Content
Indication Overview
Marketed Drugs Assessment
Marketed Details of Drugs by
Application Type
Marketed Details of Drugs
(NDA) by Marketing Status
Marketed Details of Drugs by
Patent Expiration Timeline
The Active Pharmaceutical
Ingredient (API) Manufacturers Assessment
The API Manufacturers by the
United States Drug Master File (US DMF) Status
The API Manufacturers by the
US DMF Status (Drug Specific)
Drugs Market Data and
Forecasted Sales Figures (2011-2015)
Marketed Drugs Information
Related
Reports
GlobalData's clinical trial
report, Onchocerciasis (River Blindness) Global Clinical Trials
Review, H2, 2014" provides data on the Onchocerciasis (River
Blindness) clinical trial scenario. This report provides elemental
information and data relating to the clinical trials on
Onchocerciasis (River Blindness). It includes an overview of the
trial numbers and their recruitment status as per the site of trial
conduction across the globe. The databook offers a preliminary
coverage of disease clinical trials by their phase, trial status,
prominence of the sponsors and also provides briefing pertaining to
the number of trials for the key drugs for treating Onchocerciasis
(River Blindness). This report is built using data and information
sourced from proprietary databases, primary and secondary research
and in-house analysis by GlobalData's team of industry experts.
GlobalData's clinical trial
report, Mycoses Global Clinical Trials Review, H2, 2014"
provides data on the Mycoses clinical trial scenario. This report
provides elemental information and data relating to the clinical
trials on Mycoses. It includes an overview of the trial numbers and
their recruitment status as per the site of trial conduction across
the globe. The databook offers a preliminary coverage of disease
clinical trials by their phase, trial status, prominence of the
sponsors and also provides briefing pertaining to the number of
trials for the key drugs for treating Mycoses. This report is built
using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by GlobalData's
team of industry experts.
About
Us
MarketResearchReports.biz is
the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Browse
Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz
Contact
Us
Office:
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA: Canada Toll Free:
866-997-4948
E:
sales@marketresearchreports.biz
No comments:
Post a Comment